References
Andersen, K., & Pedersen, B.K. (2008). The role of inflammation in vascular insulin resistance with focus on Il-6. Hormone and Metabolic Research, 40(9), 635-639.
Badger, A.M., Bradbeer, J.N., Votta, B., Lee, J.C., Adams, J.L., & Griswold, D.E. (1996). Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock, and immune function. Journal of Pharmacology and Experimental Therapeutics, 279(3), 1453-1461.
Barber, A.E., Coyle, S.M., Fischer, E., Smith, C., van der Poll, T., Shires, G.T., et al. (1995). Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery, 118(2), 406-410.
Bower, J.E., Ganz, P.A., Aziz, N., & Fahey, J.L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64(4), 604-611.
Branger, J., van den Blink, B., Weijer, S., Madwed, J., Bos, C.L., Gupta, A., et al. (2002). Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Journal of Immunology, 168(8), 4070-4077.
Brenner, I.K., Natale, V.M., Vasiliou, P., Moldoveanu, A.I., Shek, P.N., & Shephard, R.J. (1999). Impact of three different types of exercise on components of the inflammatory response. European Journal of Applied Physiology and Occupational Physiology, 80(5), 452-460.
Bruunsgaard, H., Galbo, H., Halkjaer-Kristensen, J., Johansen, T.L., MacLean, D.A., & Pedersen, B.K. (1997). Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. Journal of Physiology, 499(Pt. 3), 833-841.
Clarkson, P.M., Kearns, A.K., Rouzier, P., Rubin, R., & Thompson, P.D. (2006). Serum creatine kinase levels and renal function measures in exertional muscle damage. Medicine and Science in Sports and Exercise, 38(4), 623-627.
Cramp, F., & Daniel, J. (2008). Exercise for the management of cancer-related fatigue in adults. Cochrane Database of Systematic Reviews, 2, CD006145.
Dandona, P., Aljada, A., Garg, R., & Mohanty, P. (1999). Increase in plasma interleukin-10 following hydrocortisone injection. Journal of Clinical Endocrinology and Metabolism, 84(3), 1141-1144.
Dantzer, R., & Kelley, K.W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21(2), 153-160.
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G., & de Vries, J.E. (1991). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine, 174(5), 1209-1220.
Ding, A.H., Porteu, F., Sanchez, E., & Nathan, C.F. (1990). Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science, 248(4953), 370-372.
Elsea, C.R., Roberts, D.A., Druker, B.J., & Wood, L.J. (2008). Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity. PLoS ONE, 3(6), e2355.
Febbraio, M.A., Steensberg, A., Keller, C., Starkie, R.L., Nielsen, H.B., Krustrup, P., et al. (2003). Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. Journal of Physiology, 549(Pt. 2), 607-612.
Gerard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., et al. (1993). Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. Journal of Experimental Medicine, 177(2), 547-550.
Goldblatt, F., & Isenberg, D.A. (2005). New therapies for rheumatoid arthritis. Clinical and Experimental Immunology, 140(2), 195-204.
Holscher, C., Mohrs, M., Dai, W.J., Kohler, G., Ryffel, B., Schaub, G.A., et al. (2000). Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infection and Immunity, 68(7), 4075-4083.
Irvine, D., Vincent, L., Graydon, J.E., Bubela, N., & Thompson, L. (1994). The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nursing, 17(5), 367-378.
Keller, C., Keller, P., Giralt, M., Hidalgo, J., & Pedersen, B.K. (2004). Exercise normalizes overexpression of TNF-alpha in knockout mice. Biochemical and Biophysical Research Communications, 321(1), 179-182.
Keller, C., Steensberg, A., Pilegaard, H., Osada, T., Saltin, B., Pedersen, B.K., et al. (2001). Transcriptional activation of the Il-6 gene in human contracting skeletal muscle: Influence of muscle glycogen content. Faseb Journal, 15(14), 2748-2750.
Lang, C.H., Silvis, C., Deshpande, N., Nystrom, G., & Frost, R.A. (2003). Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock, 19(6), 538-546.
Lundberg, I.E., & Nader, G.A. (2008). Molecular effects of exercise in patients with inflammatory rheumatic disease. Nature Clinical Practice. Rheumatology, 4(11), 597-604.
Mant, T.G., Borozdenkova, S., Bradford, D.B., Allen, E., Amin, D.M., Toothaker, R.D., et al. (2008). Changes in HLA-DR expression, cytokine production, and coagulation following endotoxin infusion in healthy human volunteers. International Immunopharmacology, 8(5), 701-707.
Michael, Y.L., Kawachi, I., Berkman, L.F., Holmes, M.D., & Colditz, G.A. (2000). The persistent impact of breast carcinoma on functional health status: Prospective evidence from the Nurses' Health Study. Cancer, 89(11), 2176-2186.
Mock, V., Dow, K.H., Meares, C.J., Grimm, P.M., Dienemann, J.A., Haisfield-Wolfe, M.E., et al. (1997). Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncology Nursing Forum, 24(6), 991-1000.
Muhl, H., Nold, M., Chang, J.H., Frank, S., Eberhardt, W., & Pfeilschifter, J. (1999). Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells. European Journal of Immunology, 29(10), 3225-3235.
National Comprehensive Cancer Network. (2009). Clinical Practice Guidelines in Oncology™: Cancer-related fatigue [v.1.2009]. Jenkintown, PA: Author.
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., et al. (2005). Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood, 106(8), 2627-2632.
Omdal, R., & Gunnarsson, R. (2004). The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis—A pilot study. Rheumatology International, 25(6), 481-484.
Ostrowski, K., Hermann, C., Bangash, A., Schjerling, P., Nielsen, J.N., & Pedersen, B.K. (1998). A trauma-like elevation of plasma cytokines in humans in response to treadmill running. Journal of Physiology, 513(Pt. 3), 889-894.
Ostrowski, K., Rohde, T., Asp, S., Schjerling, P., & Pedersen, B.K. (1999). Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. Journal of Physiology, 515(Pt. 1), 287-291.
Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B.K. (1998). Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. Journal of Physiology, 508(Pt. 3), 949-953.
Ostrowski, K., Schjerling, P., & Pedersen, B.K. (2000). Physical activity and plasma interleukin-6 in humans—Effect of intensity of exercise. European Journal of Applied Physiology, 83(6), 512-515.
Paiva, E.S., Deodhar, A., Jones, K.D., & Bennett, R. (2002). Impaired growth hormone secretion in fibromyalgia patients: Evidence for augmented hypothalamic somatostatin tone. Arthritis and Rheumatism, 46(5), 1344-1350.
Pedersen, B.K. (2006). The anti-inflammatory effect of exercise: Its role in diabetes and cardiovascular disease control. Essays in Biochemistry, 42, 105-117.
Pedersen, B.K., & Fischer, C.P. (2007). Physiological roles of muscle-derived interleukin-6 in response to exercise. Current Opinion in Clinical Nutrition and Metabolic Care, 10(3), 265-271.
Schubert, C., Hong, S., Natarajan, L., Mills, P.J., & Dimsdale, J.E. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior, and Immunity, 21(4), 413-427.
Schwartz, A.L. (1998). Patterns of exercise and fatigue in physically active cancer survivors. Oncology Nursing Forum, 25(3), 485-491.
Segar, M.L., Katch, V.L., Roth, R.S., Garcia, A.W., Portner, T.I., Glickman, S.G., et al. (1998). The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncology Nursing Forum, 25(1), 107-113.
Steensberg, A., Fischer, C.P., Keller, C., Moller, K., & Pedersen, B.K. (2003). IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of Physiology Endocrinology and Metabolism, 285(2), E433-E437.
Steensberg, A., Keller, C., Starkie, R.L., Osada, T., Febbraio, M.A., & Pedersen, B.K. (2002). IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. American Journal of Physiology Endocrinology and Metabolism, 283(6), E1272-E1278.
Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Klarlund Pedersen, B. (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. Journal of Physiology, 529(Pt. 1), 237-242.
Thomassen, M.J., Divis, L.T., & Fisher, C.J. (1996). Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clinical Immunology and Immunopathology, 80(3, Pt. 1), 321-324.
Tidball, J.G. (2005). Inflammatory processes in muscle injury and repair. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 288(2), R345-R353.
Tilg, H., & Moschen, A.R. (2006). Adipocytokines: Mediators linking adipose tissue, inflammation, and immunity. Nature Reviews. Immunology, 6(10), 772-783.
Toft, A.D., Jensen, L.B., Bruunsgaard, H., Ibfelt, T., Halkjaer-Kristensen, J., Febbraio, M., et al. (2002). Cytokine response to eccentric exercise in young and elderly humans. American Journal of Physiology Cell Physiology, 283(1), C289-C295.
Weinblatt, M.E., Keystone, E.C., Furst, D.E., Moreland, L.W., Weisman, M.H., Birbara, C.A., et al. (2003). Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial. Arthritis and Rheumatism, 48(1), 35-45.
White, C.M., Martin, B.K., Lee, L.F., Haskill, J.S., & Ting, J.P. (1998). Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunology and Immunotherapy, 46(2), 104-112.
Wood, L.J., Nail, L.M., Gilster, A., Winters, K.A., & Elsea, C.R. (2006). Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncology Nursing Forum, 33(3), 535-542.
Wood, L.J., Nail, L.M., Perrin, N.A., Elsea, C.R., Fischer, A., & Druker, B.J. (2006). The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biological Research for Nursing, 8(2), 157-169.